A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma.
Saved in:
| Title: | A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma. |
|---|---|
| Authors: | Piperno-Neumann, S.1 (AUTHOR) sophie.piperno-neumann@curie.fr, Carlino, M. S.2,3 (AUTHOR), Boni, V.4 (AUTHOR), Loirat, D.1 (AUTHOR), Speetjens, F. M.5 (AUTHOR), Park, J. J.2 (AUTHOR), Calvo, E.4 (AUTHOR), Carvajal, R. D.6 (AUTHOR), Nyakas, M.7 (AUTHOR), Gonzalez-Maffe, J.8 (AUTHOR), Zhu, X.9 (AUTHOR), Shirley, M. D.9 (AUTHOR), Ramkumar, T.9 (AUTHOR), Fessehatsion, A.9 (AUTHOR), Burks, H. E.9 (AUTHOR), Yerramilli-Rao, P.9 (AUTHOR), Kapiteijn, E.5 (AUTHOR) |
| Source: | British Journal of Cancer. Apr2023, Vol. 128 Issue 6, p1040-1051. 12p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/s41416-022-02133-6 |
